CNS
Pulse
Conferences
Abstracts
Authors
Home
Authors
Philip Harvey
Philip Harvey
1 presentation
T105. ACTIVE AND PASSIVE DIGITAL PHENOTYPING TO MEASURE OUTCOMES IN A 12-MONTH STUDY OF XANOMELINE/ TROSPIUM CHLORIDE IN SCHIZOPHRENIA: LONGITUDINAL PREDICTION OF TOTAL CHANGES WITH EARLY LEVELS OF PHYSICAL ACTIVITY
2026 ASCP Annual Meeting